Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Biotech
Regeneron pens $2.3B Parabilis pact to develop new twist on ADCs
Regeneron ponied up $125 million in cash and an equity investment to develop a new type of ADC that could have better luck binding to target sites.
James Waldron
May 18, 2026 9:08am
Regeneron rocked by failure as melonama drug can't beat Keytruda
May 18, 2026 4:40am
Fierce Pharma
Regeneron ushers in new era with inaugural gene therapy approval
Apr 23, 2026 3:22pm
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
Apr 13, 2026 7:24am
AstraZeneca’s COPD hits breathe life into class rocked by flops
Mar 27, 2026 5:58am
Apogee data drive hype as threat to Lilly, Sanofi becomes clear
Mar 23, 2026 9:00am
